• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
UNQUOTE
  • France

3i and Cathay invest combined €180m in Ponroy

  • Alice Tchernookova
  • Alice Tchernookova
  • 04 November 2016
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

3i Group and Cathay Capital have invested a combined €180m in healthcare group Ponroy Santé, together taking a majority stake in the group.

As a result of the transaction, 3i will hold a majority stake in the group. Company executives Fabrice Cahierc (CEO), Philippe Charrier (executive chairperson) and Arnaud Ponroy (former executive chairperson) will also retain interests in the company. Cahierc and Ponroy were previously invested in the group, while Charrier is a new shareholder.

3i invested in equity from its own balance sheet, contributing a total of €150m to the round, while Cathay invested €30m. According to the GP, Ponroy has registered a 10% annual growth rate over the last four years.

3i and Cathay said in a statement they would build on the company's strength in Europe, and further develop its global presence. Ponroy Santé already has a presence in Asia (Hong-Kong, China) and the Americas. Sino-French GP Cathay is expected to play a key role in the group's expansion into the Asian market.

Debt
A debt package was provided by Natixis, BNP Paribas, Societe Generale, Bank of Ireland, ING and HSBC to support the transaction.  

Company
Founded in 1975 and headquartered in Boufféré, near Nantes, Ponroy Santé manufactures a range of natural healthcare and cosmetics products from functional and natural food supplements to natural cosmetics and hygiene products for babies and women. The group distributes its products through a chain of retailers, pharmacies, and drugstores, as well as through online sales.

Ponroy Santé operates under several brands, including Biolane, Yves Ponroy, Vitarmonyl, Manhae, Lecitone, Force G, Ultrabiotique and Naturé Moi. It manufactures most of its products in its French production plant, and exports products to 50 countries worldwide, with 35% of its sales coming from exports. According to the GP, the group currently generates €170m in revenues with EBITDA of €25m.

People
3i Group – Rémi Carnimolla (managing director); Guillaume Basquin (director).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • France
  • Consumer
  • Buyouts
  • France
  • Cathay Capital
  • 3i

More on France

Naxicap to exit ECF in SBO to PAI
Naxicap to exit ECF in SBO to PAI

Hospitality and care equipment producer marks fifth deal from PAI’s eighth flagship fund

  • France
  • 16 June 2023
Cerea Partners raises EUR 700m-plus for multi-asset food and beverage funds
Cerea Partners raises EUR 700m-plus for multi-asset food and beverage funds

France-headquartered GP is on the road for vehicles across its private equity, mezzanine and senior debt strategies

  • France
  • 12 May 2023
Montagu exits Maincare to state-owned Docaposte in off-market deal
Montagu exits Maincare to state-owned Docaposte in off-market deal

Hospital software group considered "missing piece" in buyer's healthcare digitalisation strategy

  • France
  • 17 January 2023
Mircap nears first close for debut co-investment fund
Mircap nears first close for debut co-investment fund

GP led by Michele Mezzarobba and François Pinel de Golleville will aim to raise EUR 100-120m

  • France
  • 12 December 2022

Latest News

Partners Group to release IMs for Civica sale in mid-September
  • Exits
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions
  • Investments
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • 01 September 2023
Redalpine expands leadership team amid CHF 1bn-plus fundraise
  • Venture
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • 31 August 2023
Change Ventures aims to hold final close for EUR 20m third fund by mid-2024
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds

  • 31 August 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013